Piramal Pharma Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Mar '24
Dec '23
Sep '23
Jun '23
Mar '23
Total Qtr Revenue cr
2,578.74
2,020.08
1,960.57
1,787.16
2,188.08
Other Income Qtr Cr26.3861.5149.1938.3124.50
Operating Revenues Qtr2,552.361,958.571,911.381,748.852,163.58

*All values are in Cr.

Operating Expenses Qtr
2,022.43
1,690.20
1,645.74
1,616.53
1,812.31
Operating Profit Qtr
529.93
268.37
265.64
132.32
351.27
EBIDT Qtr Cr
525.79
297.61
314.83
170.63
375.77
Depreciation Qtr
196.13
186.32
184.51
173.61
184.41
Net Profit Qtr
101.27
10.11
5.02
-98.58
50.11
Basic EPS Qtr
0.77
0.08
0.04
-0.83
0.42
Open Demat Account
+91 -

personImage
Open Demat Account
+91 -